Kamfanin Succeeder Technology Inc.

Ca²⁺ yana taka muhimmiyar rawa a cikin tsarin hada jini, musamman ma ga waɗannan fannoni:

1. Shiga cikin kunna abubuwan da ke haifar da coagulation:
Yawancin abubuwan da ke haifar da coagulation suna buƙatar haɗin Ca²⁺ lokacin da suke taka rawa. Misali, a cikin tsarin kunna abubuwan da ke haifar da coagulation IX, X, XI, XII, da sauransu, ana buƙatar Ca²⁺ ya ɗaure waɗannan abubuwan coagulation don sa su sami canje-canje na tsari da kuma fallasa cibiyar aiki, don su iya hulɗa da sauran abubuwan coagulation kuma su fara amsawar coagulation cascade.

2. Inganta samuwar hadaddun abubuwan da ke haifar da coagulation:
Ca²⁺ na iya aiki a matsayin gada don haɓaka samuwar hadaddun abubuwa tsakanin abubuwan haɗin jini. Misali, a cikin tsarin haɗin jini, Ca²⁺ na iya haɗa phospholipids masu caji mara kyau (wanda ke kan saman membranes na platelet, da sauransu) tare da abubuwan haɗin jini Xa, V, da sauransu don samar da hadaddun prothrombin, yana hanzarta tsarin canza prothrombin zuwa thrombin.

3. Kunna ƙwayoyin cuta da sakin su:
Ca²⁺ kuma yana da matuƙar muhimmanci wajen kunna da kuma sakin halayen platelets. Idan jijiyoyin jini suka lalace, platelets ɗin suna manne da ɓangaren da ya lalace, kuma Ca²⁺ yana shiga cikin platelets, yana haifar da jerin halayen sinadarai a cikin platelets, wanda ke haifar da sakin abubuwa daban-daban masu aiki daga platelets, kamar adenosine diphosphate (ADP), thromboxane A₂, da sauransu. Waɗannan abubuwan suna ƙara haɓaka tarin platelets da kuma coagulation na jini.

4. Daidaita polymers na fibrin:
A matakin ƙarshe na coagulation, fibrinogen yana canzawa zuwa fibrin monomers ƙarƙashin aikin thrombin, sannan ana haɗa fibrin monomers don samar da stable fibrin polymers ƙarƙashin aikin Ca²⁺ da coagulation factor XIII, ta haka ne ke samar da stight blood clotting don cimma manufar hemostasis. Ba tare da Ca²⁺ ba, ba za a iya haɗa fibrin monomers zuwa stable fibrin polymers ba, ba za a iya samar da thrombin yadda ya kamata ba, kuma ba za a iya haɗa jini yadda ya kamata ba.

Kamfanin Beijing Succeeder Technology Inc. (Lambar hannun jari: 688338), wanda aka kafa a shekarar 2003 kuma aka jera shi tun daga shekarar 2020, babban kamfani ne a fannin gano cutar coagulation. Mun ƙware a fannin na'urorin auna coagulation na atomatik da reagents, masu nazarin ESR/HCT, da masu nazarin hemorheology. Kayayyakinmu suna da takardar shaidar ISO 13485 da CE, kuma muna hidima ga masu amfani sama da 10,000 a duk duniya.

Gabatarwar Mai Nazari
Ana iya amfani da na'urar nazarin coagulation mai cikakken aiki ta SF-9200 (https://www.succeeder.com/fully-automated-coagulation-analyzer-sf-9200-product) don gwajin asibiti da gwajin kafin tiyata. Asibitoci da masu binciken kimiyya na likitanci suma za su iya amfani da SF-9200. Wanda ke amfani da hanyar coagulation da immunoturbidimetry, hanyar chromogenic don gwada coagulation na plasma. Kayan aikin ya nuna cewa ƙimar auna coagulation shine lokacin coagulation (a cikin daƙiƙa). Idan an daidaita kayan gwajin ta hanyar plasma daidaitawa, zai iya nuna wasu sakamako masu alaƙa.
An yi samfurin ne da na'urar bincike mai motsi, na'urar tsaftacewa, na'urar cuvettes mai motsi, na'urar dumama da sanyaya, na'urar gwaji, na'urar da aka nuna aiki, hanyar sadarwa ta LIS (wanda ake amfani da ita don firinta da ranar canja wurin zuwa Kwamfuta).
Ma'aikata da masu nazari kan inganci da inganci su ne garantin ƙera SF-9200 da kuma inganci mai kyau. Muna ba da garantin cewa kowace na'urar aiki za a duba ta kuma a gwada ta sosai. SF-9200 ya cika ƙa'idodin ƙasa na China, ƙa'idodin masana'antu, ƙa'idodin kasuwanci da ƙa'idodin IEC.